Habibe Hezer, Aysegul Karalezli, Emine Arguder, Canan Hasanoglu, Hatice Kilic, Ebru Parlak, Mukremin Er, Serpil Kus, Hulya Erguden

Retrospective evaluation of sarcoidosis cases: 10 years of experience from Turkey

Aim: Clinical features in sarcoidosis are very variable and can present with numerous phenotypes depending on organ involvements, clinical onset (acute, subacute, and chronic) and response to therapy. In this study, we aimed to evaluate the clinical findings, diagnostic methods and treatments of patients with sarcoidosis by 10-years data in our hospital in Turkey. Materials and Methods: The study was carried out between January 2018 and January 2019. The patients were screened retrospectively from the hospital information system. Clinical details were collected using a structured data collection form. Results: 172 patients were included in our study. 122 (70.9%) were female and 50 (29.1%) were male. The mean age at diagnosis was 50.18 ± 13.73 years in all patients, while female patients’ mean age was 52.86 ± 13.06, male patients’ was 43.66 ± 13.24 (p

PDF

___

1. Ramachandraiah V, Aronow W, Chandy D. Pulmonary sarcoidosis: an update. Postgrad Med 2017;129:149- 58.
2. Patterson KC, Strek ME. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc 2013;10:362-70.
3. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41.
4. Prasse A. The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis. Dtsch Arztebl Int 2016;113:565-74.
5. Arkema EV, Grunewald J, Kullberg S, et al. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J 2016;48:1690-9.
6. Baughman RP, Field S, Costabel U, et al. Sarcoidosis in America. Analysis Based on Health Care Use. Ann Am Thorac Soc 2016;13:1244-52.
7. Musellim B, Kumbasar OO, Ongen G, et al. Epidemiological features of Turkish patients with sarcoidosis. Respir Med 2009;103:907-12.
8. Freemer M, King TE Jr. The ACCESS study: characterization of sarcoidosis in the United States. Am J Respir Crit Care Med 2001;164:1754-5.
9. Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011;183:573-81.
10. Patterson KC, Chen ES. The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment. Chest 2018;153:1432-42.
11. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961;2:1165-72.
12. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
13. Gurkan OU, Celik G, Kumbasar O, et al. Sarcoidosis in Turkey: 1954-2000. Ann Saudi Med 2004;24:36-9.
14. Design of a case control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group. J Clin Epidemiol 1999;52:1173-86.
15. Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis 2018;9:227-40.
16. Beghè D, Dall'Asta L, Garavelli C, et al. Sarcoidosis in an Italian province. Prevalence and environmental risk factors. PLoS One. 2017;12:e0176859.
17. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65.
18. Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet 2014;383:1155-67.
19. Brito-Zerón P, Sellarés J, Bosch X, et al. Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences. Clin Exp Rheumatol 2016;34:380-8.
20. Lill H, Kliiman K, Altraja A. Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population. Clin Respir J 2016;10:282-90.
21. Aykan FS, Turktas H, Kokturk N, et al. Retrospective Evaluation of 100 Patients with Sarcoidosis in Gazi University, Turkey. Turk Thorac J 2014;15:155-61.
22. Karakaya B, Kaiser Y, van Moorsel CHM, et al. Löfgren's Syndrome: Diagnosis, Management, and Disease Pathogenesis. Semin Respir Crit Care Med 2017;38:463-76.
23. Myers JL, Tazelaar HD. Challenges in pulmonary fibrosis: 6—Problematic granulomatous lung disease. Thorax 2008;63:78-84.
24. Miliauskas S, Zemaitis M, Sakalauskas R. Sarcoidosis- -moving to the new standard of diagnosis? Medicina (Kaunas) 2010;46:443-6.
25. Goyal A, Gupta D, Agarwal R, Bal A, Nijhawan R, Aggarwal AN. Value of different bronchoscopic sampling techniques in diagnosis of sarcoidosis: a prospective study of 151 patients. J Bronchology Interv Pulmonol 2014;21:220-6.
26. Gupta N, Muthu V, Agarwal R, et al. Role of EBUS-TBNA in the Diagnosis of Tuberculosis and Sarcoidosis. J Cytol 2019;36:128-30.
27. Thillai M, Chang W, Chaudhuri N, et al. Sarcoidosis in the UK: insights from British Thoracic Society registry data. BMJ Open Respir Res 2019;6:e000357.
28. Trisolini R, Baughman RP, Spagnolo P, et al. Endobronchial ultrasound-guided transbronchial needle aspiration in sarcoidosis: Beyond the diagnostic yield. Respirology 2019;24:531-42.
29. Chapman JT, Mehta AC. Bronchoscopy in sarcoidosis: diagnostic and therapeutic interventions. Curr Opin Pulm Med 2003;9:402-7.
30. Shen Y, Pang C, Wu Y, et al. Diagnostic Performance of Bronchoalveolar Lavage Fluid CD4/CD8 Ratio for Sarcoidosis: A Meta-analysis. EBioMedicine 2016;8:302-8.
31. Baughman RP. Pulmonary sarcoidosis. Clin Chest Med 2004;25:521-30.
32. Pietinalho A, Ohmichi M, Hiraga Y, et al. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:159-66.
33. Ganeshan D, Menias CO, Lubner MG, et al. Sarcoidosis from Head to Toe: What the Radiologist Needs to Know. Radiographics 2018;38:1180-200.
34. Lieberman J: The specificity and nature of serumangiotensin-converting enzyme (serum ACE) elevations in sarcoidosis. Ann N Y Acad Sci 1976;278:488-97.
35. Coleman GC, Shaw PW, Balfour PC Jr, et al. Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. JACC Cardiovasc Imaging 2017;10:411-20.
36. Piekarski E, Beneli K, Rouzet F. Nuclear Imaging in sarcoidosis. Semin Nucl Med 2018;48:246-60.
37. Pirau L, Lui F. Neurosarcoidosis. 2018 Nov 27. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from http://www. ncbi.nlm.nih.gov/books/NBK534768/.
38. Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, et al. Trends and Patterns of Differences in Chronic Respiratory Disease Mortality Among US Counties, 1980-2014. JAMA 2017;318:1136-49.
39. Judson MA, Baughman RP, Thompson BW, et al. ACCESS Research Group. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:204-11.
40. Ungprasert P, Crowson CS, Achenbach SJ, et al. Hospitalization Among Patients with Sarcoidosis: A Population-Based Cohort Study 1987-2015. Lung 2017;195:411-8.